Sarah J Welsh
5PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 04, 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma.Martin H Voss, Arun A Azad, Aaron R Hansen
|Jan 21, 2022
Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle Study.Stephan Ursprung, Ramona Woitek, Mary A McLean
|Nov 09, 2021
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials.Helen Mossop, Michael J Grayling, Ferdia A Gallagher
|Sep 22, 2021
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib.Sarah J Welsh, Nicola Thompson, Anne Warren
|Apr 11, 2020
The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro.Rafia S Al-Lamki, Nicholas J Hudson, John R Bradley
Pageof 1
Frequent Collaborators
4 joint publications
Grant D Stewart
2 joint publications
Andrew N Priest
2 joint publications
Ferdia A Gallagher
1 joint publications
Anne Y Warren
1 joint publications
Kate M Fife
1 joint publications
Michael J Grayling
1 joint publications
James M S Wason
1 joint publications
Stephan Ursprung
1 joint publications
Andrew B Gill
1 joint publications
Lucian Beer
